Healwell AI Past Earnings Performance
Past criteria checks 0/6
Healwell AI's earnings have been declining at an average annual rate of -40.6%, while the Healthcare industry saw earnings growing at 16.2% annually. Revenues have been declining at an average rate of 34.4% per year.
Key information
-40.6%
Earnings growth rate
-25.8%
EPS growth rate
Healthcare Industry Growth | -6.7% |
Revenue growth rate | -34.4% |
Return on equity | -26.8% |
Net Margin | -77.8% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Is Healwell AI (TSE:AIDX) A Risky Investment?
Nov 03Why Investors Shouldn't Be Surprised By Healwell AI Inc.'s (TSE:AIDX) P/S
Sep 10Healwell AI Inc.'s (TSE:AIDX) Intrinsic Value Is Potentially 46% Above Its Share Price
Jun 14Healwell AI Inc. (TSE:AIDX) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected
Mar 11MCI Onehealth Technologies Inc.'s (TSE:DRDR) Stock Retreats 57% But Revenues Haven't Escaped The Attention Of Investors
Apr 17Revenue & Expenses Breakdown
How Healwell AI makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 26 | -20 | 35 | 3 |
30 Jun 24 | 14 | -17 | 23 | 4 |
31 Mar 24 | 10 | -31 | 19 | 4 |
31 Dec 23 | 7 | -32 | 14 | 5 |
30 Sep 23 | 5 | -27 | 13 | 6 |
30 Jun 23 | 7 | -29 | 13 | 7 |
31 Mar 23 | 9 | -21 | 13 | 8 |
31 Dec 22 | 10 | -18 | 14 | 8 |
30 Sep 22 | 24 | -21 | 23 | 5 |
30 Jun 22 | 34 | -17 | 27 | 4 |
31 Mar 22 | 41 | -17 | 31 | 2 |
31 Dec 21 | 48 | -16 | 33 | 0 |
30 Sep 21 | 45 | -13 | 29 | 1 |
30 Jun 21 | 42 | -6 | 27 | 0 |
31 Mar 21 | 38 | -3 | 21 | 0 |
31 Dec 20 | 39 | -1 | 17 | 0 |
30 Sep 20 | 40 | 1 | 10 | 0 |
31 Dec 19 | 46 | 0 | 6 | 0 |
31 Dec 18 | 45 | 0 | 6 | 0 |
31 Dec 17 | 44 | 0 | 5 | 0 |
Quality Earnings: AIDX is currently unprofitable.
Growing Profit Margin: AIDX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AIDX is unprofitable, and losses have increased over the past 5 years at a rate of 40.6% per year.
Accelerating Growth: Unable to compare AIDX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AIDX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.4%).
Return on Equity
High ROE: AIDX has a negative Return on Equity (-26.78%), as it is currently unprofitable.